Stock CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News CannPal Animal Therapeutics Limited

Equities

CP1

AU000000CP17

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Layton Mills and Margaret Curtis agreed to acquire 52% stake in CannPal Animal Therapeutics Limited from AusCann Group Holdings Ltd for AUD1.
CI
AusCann Group Holdings Ltd completed the acquisition of CannPal Animal Therapeutics Limited from Merchant Opportunities Fund, managed by Merchant Funds Management Pty Ltd and others.
CI
Cannpal Animal Therapeutics : Narrows Fiscal H1 Loss on Higher Revenue
MT
Cannpal Animal Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2020
CI
AusCann : CannPal Managing Director to Lead Merged Company Formed With AusCann; CannPal Rises 11%
MT
AusCann Group Holdings Ltd (ASX:AC8) and CannPal Enter Into Scheme of Arrangement
AQ
AusCann Group Holdings Ltd entered into a scheme implementation deed to acquire CannPal Animal Therapeutics Limited from Merchant Opportunities Fund, managed by Merchant Funds Management Pty Ltd and others for AUD 16.9 million.
CI
CannPal Animal Therapeutics Limited Announces Resignation of Max Johnston as Non-Executive Director
CI
CannPal Animal Therapeutics : CBD Substantially Improves Atopic Dermatitis Symptoms in Dogs
AQ
CannPal Animal Therapeutics Limited Announces Completion of its Safety and Efficacy Study for DermaCann
CI
CannPal Animal Therapeutics Limited Announces FDA Establishes Investigational New Animal Drug file for CPAT-01
CI
Cannpal Animal Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2019
CI
CannPal Animal Therapeutics Limited Enters into Exclusive Licensing Agreement with Commonwealth Scientific and Industrial Research Organisation
CI
49,365,405 Ordinary Shares of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
2,000,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
625,000 Class A Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
1,500,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
7,250,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
625,000 Class B Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
625,000 Class C Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CP1 Stock
  4. News CannPal Animal Therapeutics Limited